Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Ongoing drug recalls - open right now

Every FDA drug recall whose status is still Ongoing: the firm is still removing product from the market, or the FDA has not yet closed the file. Some were opened years ago and never formally terminated, so check the initiation date as well as the status.

2,760 recalls, newest first.

Class III · Low risk

Ramipril Capsules

Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.

Ongoing Labeling / mix-up Actavis Laboratories, FL, Inc. NDC 16252-570-30 D-0118-2017
Class II · Moderate risk

LGD-Xtreme

Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033

Ongoing Unapproved drug Invisiblu International LLC D-0910-2016
Class III · Low risk

Magnesium Sulfate Inj.

Failed pH Specifications: Confirmed high out of specification (OOS) results for pH.

Ongoing Failed specification Hospira Inc. NDC 0409-2168-02 D-0854-2016

Recalls by year